Yi Zhang is interested in how epigenetic modification-mediated dynamic changes in chromatin structure affect gene expression, cell lineage commitment, stem cell pluripotency and self-renewal, brain reward and addiction, and the development and treatment of human diseases.
Epigenetic modifications, particularly DNA methylation and covalent histone modifications, play an important role in regulating chromatin dynamics and therefore have a significant impact on gene expression. My lab is interested in how epigenetic modification-mediated dynamic changes in chromatin structure affect gene expression, cell lineage commitment, stem cell pluripotency, and stem cell self-renewal, as well as epigenetic mechanisms of drug addiction. I am also interested in how misregulation of epigenetic factors contributes to the development of diseases such as diabetes, neurological diseases, and cancer, as well as the development of cancer drug resistance. My long-term goal is to apply what we have learned in basic research to the study of human diseases.
Over the past decade, my lab has worked on a number of projects that span many aspects of epigenetics and chromatin modifications, including (1) the ATP-dependent nucleosome-remodeling and histone deacetylase complex NuRD; (2) various histone methyltransferases, such as EZH2, hDOT1, ESET, SET7, SET8, and PRMT1; (3) various histone demethylases, such as the JmjC-family proteins, JHDM1A, JHDM2A, JHDM3A, RBP2, PLU-1, JMJD3, UTX, and Lid; (4) histone H2A ubiquitin E3 ligase PRC1; and (5) the Ten Eleven Translocation (Tet) family of 5-methylcytosine dioxygenases. The general approach to these projects involved biochemical purification and functional characterization of these enzymes in vitro and in cell culture, followed by biological characterization in mouse models. The proof-of-concept studies have uncovered a link between several of these enzymes and various diseases, such as metabolic syndrome and cancer.
Zhang (Yi) Research Abstract Slideshow
Figure 1: Mouse embryos at different developmental stages.
Azusa Inoue and Shinpei Yamaguchi
Figure 2: Mouse ESCs stained with alkaline phosphatase.
Figure 3: Passive dilution of 5hmC during preimplantation development.
Passive dilution of 5hmC during preimplantation development. Mitotic chromosomes of 2-cell embryo is stained with 5mC (green) and 5hmC (red) antibodies.
Courtesy of Yi Zhang
Figure 4: Staining of a blastocyst embryo with Oct4 (green) and Cdx2 (red) antibodies.
Building upon our strength in protein biochemistry, my lab has recently broadened our research interests to include epigenetic mechanisms in embryonic development, stem cell reprogramming, drug addiction, and the development of cancer drug resistance.
Current lines of investigation include the following:
- Dynamic DNA methylation and the underlying mechanisms
- Epigenetic and chromatin changes and their molecular basis in preimplantation embryos
- Epigenetic mechanism of cell reprogramming by somatic cell nuclear transfer
- Role of long noncoding RNAs in epigenetic and chromatin regulation
- Epigenetic mechanisms of drug addiction and cancer drug resistance
- The use of the information gained from these investigations for the development of treatments for human diseases, such as cancer and drug addiction
- Development of genomic and epigenomic techniques applicable to the molecular analysis of small numbers of cells
To address questions in these areas, we have expanded our ability to perform a wide range of state-of-the-art biological techniques, including single-cell live imaging, cell lineage tracing in the mouse preimplantation embryo, iPS cell generation and differentiation, stem cell reprogramming by somatic cell nuclear transfer, bone marrow transplantation, high-throughput epigenomic analysis, and mouse genetics.
Grants from the National Institutes of Health provided partial support for these projects.
As of March 10, 2016